Total Payments
$17,621
2024 Payments
$2,328
Companies
66
Transactions
1,164
Medicare Patients
7,054
Medicare Billing
$578,689
Payment Breakdown by Category
Food & Beverage$17,513 (99.4%)
Education$107.99 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,513 | 1,159 | 99.4% |
| Education | $107.99 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,642 | 123 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,523 | 112 | $0 (2024) |
| Lilly USA, LLC | $1,267 | 78 | $0 (2024) |
| Novo Nordisk Inc | $1,222 | 166 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,078 | 50 | $0 (2024) |
| Amgen Inc. | $934.72 | 49 | $0 (2024) |
| Corcept Therapeutics | $847.41 | 36 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $839.69 | 59 | $0 (2024) |
| Allergan, Inc. | $829.34 | 60 | $0 (2020) |
| Merck Sharp & Dohme LLC | $745.71 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,328 | 136 | Novo Nordisk Inc ($328.12) |
| 2023 | $3,306 | 193 | ABBVIE INC. ($415.66) |
| 2022 | $2,923 | 197 | Biohaven Pharmaceutical Holding Company Ltd. ($387.89) |
| 2021 | $2,828 | 219 | AbbVie Inc. ($426.81) |
| 2020 | $1,645 | 103 | Allergan, Inc. ($368.12) |
| 2019 | $1,524 | 105 | Takeda Pharmaceuticals U.S.A., Inc. ($362.97) |
| 2018 | $1,747 | 111 | Takeda Pharmaceuticals U.S.A., Inc. ($469.50) |
| 2017 | $1,321 | 100 | Merck Sharp & Dohme Corporation ($177.53) |
All Payment Transactions
1,164 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.55 | General |
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.48 | General |
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Biological | ||||||
| 10/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,749 | 2,511 | $255,457 | $151,277 |
| 2022 | 23 | 1,995 | 2,803 | $276,437 | $163,909 |
| 2021 | 22 | 1,803 | 2,632 | $265,590 | $156,273 |
| 2020 | 20 | 1,507 | 2,159 | $199,655 | $107,229 |
Total Patients
7,054
Total Services
10,105
Medicare Billing
$578,689
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 304 | 490 | $78,026 | $43,205 | 55.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 378 | 628 | $76,520 | $38,204 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 260 | 260 | $42,690 | $34,317 | 80.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 32 | 32 | $11,105 | $9,044 | 81.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 154 | 154 | $6,160 | $4,885 | 79.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 153 | 153 | $6,120 | $4,807 | 78.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 114 | 122 | $9,201 | $4,511 | 49.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $3,800 | $2,857 | 75.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,010 | $2,515 | 83.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 43 | 43 | $1,720 | $1,351 | 78.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 25 | 28 | $2,790 | $1,205 | 43.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 31 | 35 | $2,500 | $1,081 | 43.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 17 | 22 | $2,225 | $978.40 | 44.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 33 | 57 | $1,995 | $852.72 | 42.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 52 | $1,915 | $570.82 | 29.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 74 | $1,480 | $322.73 | 21.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 48 | 239 | $1,685 | $187.62 | 11.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 17 | $425.00 | $161.84 | 38.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $780.00 | $141.72 | 18.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 21 | 45 | $1,110 | $48.02 | 4.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 16 | $200.00 | $33.32 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 364 | 612 | $98,183 | $56,498 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 398 | 602 | $72,568 | $35,620 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 264 | 264 | $42,450 | $35,616 | 83.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 120 | 129 | $9,675 | $5,424 | 56.1% |
About Dr. William Holvik, M.D
Dr. William Holvik, M.D is a Family Medicine healthcare provider based in Visalia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346225364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Holvik, M.D has received a total of $17,621 in payments from pharmaceutical and medical device companies, with $2,328 received in 2024. These payments were reported across 1,164 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($17,513).
As a Medicare-enrolled provider, Holvik has provided services to 7,054 Medicare beneficiaries, totaling 10,105 services with total Medicare billing of $578,689. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Visalia, CA
- Active Since 12/13/2005
- Last Updated 11/20/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346225364
Products in Payments
- REXULTI (Drug) $950.19
- Korlym (Drug) $847.41
- VRAYLAR (Drug) $803.60
- FARXIGA (Drug) $755.03
- NURTEC ODT (Drug) $753.62
- Trintellix (Drug) $732.09
- TRINTELLIX (Drug) $632.21
- Ozempic (Drug) $597.10
- UBRELVY (Drug) $545.63
- MOUNJARO (Drug) $437.05
- Kerendia (Drug) $413.62
- EMGALITY (Drug) $399.01
- JANUVIA (Drug) $365.86
- Auvelity (Drug) $342.88
- Aimovig (Biological) $326.56
- JARDIANCE (Drug) $322.24
- TRULICITY (Drug) $310.84
- QULIPTA (Drug) $308.62
- LINZESS (Drug) $304.15
- TRELEGY ELLIPTA (Drug) $277.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Visalia
Dr. Mark Tetz, M.d, M.D
Family Medicine — Payments: $14,823
Family Medicine $14,823
Elizabeth Sasaki, D.o, D.O
Family Medicine — Payments: $12,522
Family Medicine $12,522
Dr. Christopher Rodarte, M.d, M.D
Family Medicine — Payments: $12,300
Family Medicine $12,300
Dr. Brandon Sorensen, M.d, M.D
Family Medicine — Payments: $11,625
Family Medicine $11,625
Mirella Younes, Md, MD
Family Medicine — Payments: $7,247
Family Medicine $7,247
Marwan Zoghbi, Md, MD
Family Medicine — Payments: $6,401
Family Medicine $6,401